ArcticZymes Technologies ASA (LTS:0DRV) Short Interest


LTS:0DRV ArcticZymes Technologies ASA LTS:0DRV
76 GF Score
Price kr20.90
GF Value kr25.75
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0DRV vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ArcticZymes Technologies ASA Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Short Interest falls into.


LTS:0DRV
76GF Score
ArcticZymes Technologies ASA LTS:0DRV
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr20.90 is trading 18.8% below its estimated GF Value™ of kr25.75. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for LTS:0DRV:

  • Short Interest:
  • GF Value™: kr25.75 vs. price of kr20.90 (18.8% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:SwedenAZT:Norway
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
76GF Score

Get the complete analysis for LTS:0DRV

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.90
Price
kr25.75
GF Value